Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Viral Plaque Reduction Assay from US Patent US9233921: "Potent poxvirus inhibitor"
Assay data:6 Active, 4 Activity ≤ 1 µM, 34 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition Assay from US Patent US9211296: "Therapeutic compounds for blocking DNA synthesis of POX viruses"
Assay data:17 Active, 1 Activity ≤ 1 µM, 35 Tested
Antiviral activity against Vaccinia virus infected in human E6SM cells
Assay data:1 Tested
SummaryPubMed Citation
Antiviral activity against Vaccinia virus infected in human MT4 cells measured after 5 days by MTT assay
Antiviral activity against ectromelia virus K-1 infected in Vero cells measured after 4 days by colorimetric assay
Assay data:4 Active, 1 Activity ≤ 1 µM, 7 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against Cowpox virus Grishak infected in Vero cells measured after 4 days by colorimetric assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 7 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in Vero cells measured after 4 days by colorimetric assay
Assay data:5 Active, 3 Activity ≤ 1 µM, 20 Tested
Antiviral activity against Vaccinia virus infected in HEL cells assessed as reduction in virus-induced cytopathic effect by microscopic analysis
Assay data:6 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as reduction in cell survival incubated for 4 days by neutral red dye based colorimetric analysis
Assay data:15 Active, 3 Activity ≤ 1 µM, 20 Tested
Antiviral activity against Vaccinia virus infected in human HELF cells assessed as reduction in virus-induced cytopathogenicity incubated for 7 days by microscopic analysis
Assay data:18 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as inhibition of viral replication after 4 days by neural red dye-based spectrophotometric method
Assay data:2 Active, 15 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity
Assay data:20 Tested
Antiviral activity against Vaccinia virus Lederle infected in HEL cells assessed as inhibition of virus-induced cytopathic effect
Antiviral activity against Vaccinia virus infected in human HEL cells assessed as inhibition of virus-induced cytopathic effect after 3 days by microscopic method
Assay data:1 Active, 34 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in African green monkey Vero cells assessed as inhibition of viral reproduction after 4 days by neural red dye-based assay
Assay data:11 Active, 19 Tested
Antiviral activity against Vaccinia virus Lederle infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity
Assay data:2 Active, 2 Activity ≤ 1 µM, 9 Tested
Antiviral activity against Vaccinia virus Copenhagen infected in HFF cells
Assay data:2 Tested
Antiviral activity against Vaccinia virus infected in HEL cells assessed as reduction in viral cytopathic effect
Assay data:13 Tested
Assay data:4 Active, 28 Tested
Antiviral activity against VV Elstree ATCC VR-1549 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay
Assay data:28 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on